Publication | Closed Access

Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations

HypertensionBenazepril HydrochlorideAntihypertensive TherapyPharmacologyCardiovascular PharmacologyPharmacotherapySpecial PopulationsMedicinePharmacokineticsDrug Resistance